Evidence map›Paper›PMID 34830364›Full record

ArticleInternational journal of molecular sciences2021

Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation.

Rebecca Linnenberger, Jessica Hoppstädter, Selina Wrublewsky, Emmanuel Ampofo, Alexandra K Kiemer

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Macrophages in immunoregulation and therapeutics.Signal transduction and targeted therapy · 2023
    Review
  11. Review
  12. Simvastatin InhibitsInternational journal of molecular sciences · 2022
    Article
  13. Macrophage Polarization: Learning to Manage It.International journal of molecular sciences · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rebecca LinnenbergerDepartment of Pharmacy, Pharmaceutical Biology, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany.
Jessica HoppstädterDepartment of Pharmacy, Pharmaceutical Biology, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany.
Selina WrublewskyInstitute of Clinical and Experimental Surgery, Saarland University, 66424 Homburg, Germany.
Emmanuel AmpofoInstitute of Clinical and Experimental Surgery, Saarland University, 66424 Homburg, Germany.ORCID 0000-0002-1886-5657
Alexandra K KiemerDepartment of Pharmacy, Pharmaceutical Biology, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany.ORCID 0000-0002-7224-9900
Saarland University · DE

Funding

Deutsche Forschungsgemeinschaft KI702/10-4Deutsche Forschungsgemeinschaft KI702/14-1
6 · The paper itself

Abstract

Statins represent the most prescribed class of drugs for the treatment of hypercholesterolemia. Effects that go beyond lipid-lowering actions have been suggested to contribute to their beneficial pharmacological properties. Whether and how statins act on macrophages has been a matter of debate. In the present study, we aimed at characterizing the impact of statins on macrophage polarization and comparing these to the effects of bempedoic acid, a recently registered drug for the treatment of hypercholesterolemia, which has been suggested to have a similar beneficial profile but fewer side effects. Treatment of primary murine macrophages with two different statins, i.e., simvastatin and cerivastatin, impaired phagocytotic activity and, concurrently, enhanced pro-inflammatory responses upon short-term lipopolysaccharide challenge, as characterized by an induction of tumor necrosis factor (TNF), interleukin (IL) 1β, and IL6. In contrast, no differences were observed under long-term inflammatory (M1) or anti-inflammatory (M2) conditions, and neither inducible NO synthase (iNOS) expression nor nitric oxide production was altered. Statin treatment led to extracellular-signal regulated kinase (ERK) activation, and the pro-inflammatory statin effects were abolished by ERK inhibition. Bempedoic acid only had a negligible impact on macrophage responses when compared with statins. Taken together, our data point toward an immunomodulatory effect of statins on macrophage polarization, which is absent upon bempedoic acid treatment.

Indexed as

AnimalsAnticholesteremic AgentsCholesterolDicarboxylic AcidsFatty AcidsHEK293 CellsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMacrophage ActivationMacrophagesMice8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acidAnticholesteremic AgentsCholesterolDicarboxylic AcidsFatty AcidsHydroxymethylglutaryl-CoA Reductase Inhibitorsarginasebone marrow-derived macrophagesGILZHMG-CoA reductaseinflammasomeKLF2LPSnatural compoundsphagocytosispolarization

Identifiers

PMID34830364
PMCPMC8623589
OpenAlexW3215724670

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.